EARLY FECAL CALPROTECTIN LEVELS PREDICT POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE: DATA FROM THE REPREVIO TRIAL

Lotte Oldenburg  ¹     Carlos Taxonera Samso  ²     Antonio López San Román  ³     Pilar Nos Mateu  ⁴     Silvio Danese  ⁵     Alessandro Armuzzi  ⁶     Xavier Roblin  ⁷     Laurent Peyrin-Biroulet  ⁸     Rachel West  ⁹     Ben J.M. Witteman  ¹⁰     Marjolijn Duijvestein  ¹¹     Krisztina Barbara Gecse  ¹¹     Melanie Hulshoff  ¹¹     Nahid Mostafavi  ¹²     Esmé Clasquin  ¹²     Yoram Bouhnik  ¹³     David Laharie  ¹⁴     Geert R. D'Haens  ^15    
1 Amsterdam University Medical Center, Amsterdam, Netherlands
² Hospital Clinico, Madrid, Spain
³ Hospital Ramon Y Cajal, Madrid, Spain
⁴ Hospital La Fe, Valencia, Spain
⁵ Instituto Clinico Humanitas, Rozzano, Italy
⁶ IBD Center, IRCCS Humanitas Research Hospital, Milan, Italy
⁷ University of St. Etienne, Saint Etienne, France
⁸ Nancy University Hospital, Vandoeuvre-les-Nancy, France
⁹ Sint Franciscus Gasthuis, Rotterdam, Netherlands
¹⁰ Ziekenhuis Gelderse Vallei, Ede, Netherlands
¹¹ Radboudumc, Nijmegen, Netherlands
¹² Amsterdam UMC, Amsterdam, Netherlands
¹³ CHU Beaujon, IBD and Nutrition, Clichy, France
¹⁴ CHU de Bordeaux Hopital Haut-Leveque, Pessac cedex, France
¹⁵ AMC Amsterdam Inflammatory Bowel Disease Centre, Amsterdam, Netherlands

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)